By Colleen Murphy | December 13, 2023
"Merck later admitted its lawsuit had no merit because it had failed to disclose prior art to the United States Patent and Trademark Office that would have resulted in the denial of patent protection for Zetia," the complaint said. "But simply by initiating the litigation, Merck triggered a 30-month stay, which precluded the Food & Drug Administration from granting final approval of Glenmark's ANDA."
New York Law Journal | Analysis
By Karen Hoffman Lent and Kenneth Schwartz | December 11, 2023
Antitrust developments in the health care and pharmaceutical industries were exceptionally active in 2023. From the FTC's challenge of a merger between Amgen and Horizon Therapeutics, to joint agency withdrawal of well-established health care merger policy statements, to agency interest in pharmacy benefit managers, the authors review some of the most notable antitrust activity in the health care and pharmaceutical industries over the past year.
By ALM Staff | December 11, 2023
This suit was surfaced by Law.com Radar. Read the complaint here.
By Lisa Willis | December 8, 2023
"This is a case that goes back 20 years, so the damages are substantial," said the Miami attorney representing the MDL
By Ross Todd | December 7, 2023
Williams & Connolly's trial-ready focus guides clients' toughest challenges.
By Isha Marathe | December 4, 2023
The Federal Trade Commission submitted a comment to the U.S. Copyright Office voicing its intention to investigate the copyright practices of AI developers who they believe are engaging in unfair competition—whether the companies infringed copyright or not.
By Amanda O'Brien | December 4, 2023
Roberta Liebenberg, one of The American Lawyer's 2023 Lifetime Achievement honorees, has blazed a path not only in the antitrust bar, but for women attorneys everywhere.
National Law Journal | Expert Opinion
By Adam J. Levitt | December 4, 2023
Arguing Class Actions is a monthly column for the National Law Journal written by DiCello Levitt's Adam J. Levitt.
By Maydeen Merino | December 1, 2023
The agency has signaled its "desire to make a sharp change" through rulemaking but has yet to make lasting alterations through Congress or the courts, said former acting FTC Chair Maureen Ohlhausen.
The Legal Intelligencer | Commentary
By Carl W. Hittinger and Jeffrey E. Liskov | November 28, 2023
In the wide-ranging AI executive order, the White House provides a road map for its policy positions and administrative priorities with respect to the rapidly developing and expanding advent of artificial intelligence.
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
ABOUT THIS RECRUITMENTOur attorneys face some of the most challenging, cutting-edge legal issues in the environmental field. As such, we ar...
Hofstra University enrolls over 6,000 undergraduate students and nearly 4,000 graduate students in 13 schools, which feature a variety of de...
McCarter & English, LLP is actively seeking a patent associate, patent agent, or technical specialist for its Intellectual Property Prac...